Advertisement

Search Results for "Novartis Nda"

10:10 EDT 24th May 2013 | BioPortfolio

Original Source: Novartis yanks imatinib PAH NDA; FDA wants more data, cancels AdCom

The first sign there may be trouble with Novartis' new drug application (NDA) for imatinib as a pulmonary arterial hypertension (PAH) treatment came on 15 August when the US FDA called off the 14 September meeting of its Cardiovascular and Renal.....

Matching Channels

Novartis

Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals,...

Influenza Vaccine Novartis

Rabies Vaccine Novartis

Influenza Vaccine H5N1 Novartis

Interleukin-2 receptor Mab rDNA Novartis

Matching News

Novartis: M&A activity 2005-2013

Novartis has announced 18 M&A deals since 2005, with the lead deals being the acquisition of Alcon and Fougera. Abstracted from: Partnering Deals and Alliances with Novartis Novartis is involved i...

Novartis weiht neues Gebäude in Nyon-Prangins ein

Joseph Jimenez CEO Novartis Basel -Novartis hat nach umfangreichen Renovierungs- und Modernisierungsarbeiten heute das Gebäude eingeweiht, in dem sich die Labors und Büros für die Forschung, Entwic...

Novartis and Foundation Medicine in collaboration agreement for genomic information for clinical oncology programs

Foundation Medicine announced a new agreement with Novartis to provide comprehensive genomic analysis in support of Novartis’ clinical oncology programs. Novartis plans to use Foundation Medicine’...

Zweite Klage gegen Novartis in USA: Eine Tochterfirma von Novartis soll in den USA Schmiergelder in ...

Eine Tochterfirma von Novartis soll in den USA Schmiergelder in Millionenhöhe an Ärzte gezahlt haben, damit diese vor allem Novartis-Medikamente verschreiben. Nun hat die Staatsanwaltschaft erneut ....

Partnering with Novartis: Partners for innovation and success

Novartis is a top pharma company active in partnering, licensing and M&A in pharmaceuticals. The path from scientific breakthrough to successful pharmaceutical brand depends on mobilizing the best...

Novartis presents data on respiratory drugs

ZURICH, Sept 3 (Reuters) - Novartis AG : * Novartis data at ERS shows efficacy of once-daily copd

Builder of Novartis Is Stepping Down

As Novartis Chairman Daniel Vasella steps down from the company he helped build over 25 years, he leaves behind one of the health-care industry's most admired firms—but also some shareholder resentm...

Novartis

Novartis is a top pharmaceutical company based in Basel, Switzerland. The company was founded in 1996, through the merger of Ciby-Geigy (Ciba formed in 1856 and Geigy in 1758) and Sandoz (formed 1886)...

Matching PubMed Articles

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement